In the US, Neulasta (pegfilgrastim systemic) is a member of the drug class colony stimulating factors and is used to treat Neutropenia Associated with Chemotherapy and Neutropenia Associated with Radiation.
Ingredient matches for Neulasta
Pegfilgrastim is reported as an ingredient of Neulasta in the following countries:
- Croatia (Hrvatska)
- Czech Republic
- South Korea
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.